Results 181 to 190 of about 6,404 (193)

Zoster Vaccine Recombinant, Adjuvanted

2020
openaire   +1 more source

Development of Recombinant Varicella-Zoster Virus Vaccines

1999
A M, Arvin, S, Mallory, J F, Moffat
openaire   +2 more sources

Recombinant Varicella Zoster vaccine in haemodialysis facilities: adherence and safety

Journal of Nephrology, 2023
Martino FK, Pini S, Scaparrotta G, Schirinzi M, Gnappi M, Fragasso A, Zanella R, Naso E, De Giorgi ML, Carraro G, Nalesso F, Calò LA.   +11 more
openaire   +2 more sources

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine

Journal of Infectious Diseases, 2022
Andrea Callegaro, Wivine Burny, Caroline Hervé   +2 more
exaly  

Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine

Clinical Infectious Diseases, 2020
Myron J Levin, Adriana Weinberg, Levin Myron J   +2 more
exaly  

Adjuvanted recombinant zoster vaccine and live attenuated zoster vaccine are vastly different

Vaccine
openaire   +2 more sources

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live

Human Vaccines and Immunotherapeutics, 2019
Desmond Curran, Brandon J Patterson, Desirée Van Oorschot   +2 more
exaly  

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial

Vaccine, 2018
Airi Poder, Igwebuike Enweonye, Thomas C Heineman   +2 more
exaly  

Safety monitoring of Shingrix recombinant zoster vaccine

Reactions Weekly, 2019
openaire   +1 more source

Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021–23

Vaccine
Pasquale Stefanizzi, Lorenza Moscara, Andrea Martinelli   +2 more
exaly